Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 185, doi. 10.1177/1756283X11399115
- By:
- Publication type:
- Article
Works matching IS 1756283X AND DT 2011 AND VI 4 AND IP 3
Results: 6
1
2
Adopting new enrollment criteria for pharmaceutical trials in constipation: look before leaping.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 165, doi. 10.1177/1756283X11405563
- By:
- Publication type:
- Article
3
Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 169, doi. 10.1177/1756283X11402118
- By:
- Publication type:
- Article
4
Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 199, doi. 10.1177/1756283X11401774
- By:
- Publication type:
- Article
5
Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 159, doi. 10.1177/1756283X11401773
- By:
- Publication type:
- Article
6
Diagnosis and management of iron deficiency anemia in the 21st century.
- Published in:
- Therapeutic Advances in Gastroenterology, 2011, v. 4, n. 3, p. 177, doi. 10.1177/1756283X11398736
- By:
- Publication type:
- Article